ISG15: The immunological kin of ubiquitin

Seminars in Cell and Developmental Biology

Volumn 15, Issue 2, 2004, Pages 237-246

  Ritchie, Kenneth J ^a   Zhang, Dong Er ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Interferon; ISG15; ISGylation; Ubiquitin

Indexed keywords

INTERFERON; INTERFERON STIMULATED GENE 15; NEDD8 PROTEIN; PROTEASOME; PROTEIN; SUMO 1 PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

BUDDING; CANCER CELL CULTURE; CELL LINE; CONJUGATION; GENE EXPRESSION; GENETIC CODE; HUMAN; IMMUNE RESPONSE; MEDICAL RESEARCH; NONHUMAN; NUCLEOTIDE SEQUENCE; PREGNANCY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN MODIFICATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UBIQUITINATION; VIRUS INFECTION;

EID: 1342321745     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2003.12.005     Document Type: Article

References (82)

1. Tannenbaum C.S., Hamilton T.A. Immune-inflammatory mechanisms in IFNgamma-mediated anti-tumor activity. Semin. Cancer Biol. 10:2000;113-123.
2. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67:1998;227-264.
3. Farrell P.J., Broeze R.J., Lengyel P. Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells. Nature. 279:1979;523-525.
4. Korant B.D., Blomstrom D.C., Jonak G.J., Knight E. Jr. Interferon-induced proteins. Purification and characterization of a 15,000-dalton protein from human and bovine cells induced by interferon. J. Biol. Chem. 259:1984;14835-14839.
5. Blomstrom D.C., Fahey D., Kutny R., Korant B.D., Knight E. Jr. Molecular characterization of the interferon-induced 15-kDa protein. Molecular cloning and nucleotide and amino acid sequence. J. Biol. Chem. 261:1986;8811-8816.
6. Reich N., Evans B., Levy D., Fahey D., Knight E. Jr., Darnell J.E. Jr. Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc. Natl. Acad. Sci. U.S.A. 84:1987;6394-6398.
7. Knight E. Jr., Fahey D., Cordova B., Hillman M., Kutny R., Reich N.et al. A 15-kDa interferon-induced protein is derived by COOH-terminal processing of a 17-kDa precursor. J. Biol. Chem. 263:1988;4520-4522.
8. Potter J.L., Narasimhan J., Mende-Mueller L., Haas A.L. Precursor processing of pro-ISG15/UCRP, an interferon-beta-induced ubiquitin-like protein. J. Biol. Chem. 274:1999;25061-25068.
9. Haas A.L., Ahrens P., Bright P.M., Ankel H. Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J. Biol. Chem. 262:1987;11315-11323.
10. Kessler D.S., Levy D.E., Darnell J.E. Jr. Two interferon-induced nuclear factors bind a single promoter element in interferon-stimulated genes. Proc. Natl. Acad. Sci. U.S.A. 85:1988;8521-8525.
11. Tanaka N., Taniguchi T. The interferon regulatory factors and oncogenesis. Semin. Cancer Biol. 10:2000;73-81.
12. Nguyen H., Hiscott J., Pitha P.M. The growing family of interferon regulatory factors. Cytokine Growth Factor Rev. 8:1997;293-312.
13. Darnell J.E. Jr. STATs and gene regulation. Science. 277:1997;1630-1635.
14. Hiscott J., Pitha P., Genin P., Nguyen H., Heylbroeck C., Mamane Y.et al. Triggering the interferon response: the role of IRF-3 transcription factor. J. Interferon Cytokine Res. 19:1999;1-13.
15. Au W.C., Moore P.A., Lowther W., Juang Y.T., Pitha P.M. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc. Natl. Acad. Sci. U.S.A. 92:1995;11657-11661.
16. Tenen D.G., Hromas R., Licht J.D., Zhang D.E. Transcription factors, normal myeloid development, and leukemia. Blood. 90:1997;489-519.
17. McKercher S.R., Torbett B.E., Anderson K.L., Henkel G.W., Vestal D.J., Baribault H.et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15:1996;5647-5658.
18. Scott E.W., Simon M.C., Anastasi J., Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 265:1994;1573-1577.
19. Meraro D., Gleit-Kielmanowicz M., Hauser H., Levi B.Z. IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: characterization of a new subtype of IFN-stimulated response element. J. Immunol. 168:2002;6224-6231.
20. Rosenbauer F., Waring J.F., Foerster J., Wietstruk M., Philipp D., Horak I. Interferon consensus sequence binding protein and interferon regulatory factor-4/Pip form a complex that represses the expression of the interferon-stimulated gene-15 in macrophages. Blood. 94:1999;4274-4281.
21. Manthey C.L., Wang S.W., Kinney S.D., Yao Z. SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J. Leukoc. Biol. 64:1998;409-417.
22. Li J., Peet G.W., Balzarano D., Li X., Massa P., Barton R.W.et al. Novel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition. J. Biol. Chem. 276:2001;18579-18590.
23. Nicholl M.J., Robinson L.H., Preston C.M. Activation of cellular interferon-responsive genes after infection of human cells with herpes simplex virus type 1. J. Gen. Virol. 81:2000;2215-2218.
24. Mossman K.L., Macgregor P.F., Rozmus J.J., Goryachev A.B., Edwards A.M., Smiley J.R. Herpes simplex virus triggers and then disarms a host antiviral response. J. Virol. 75:2001;750-758.
25. Roberts E.S., Zandonatti M.A., Watry D.D., Madden L.J., Henriksen S.J., Taffe M.A.et al. Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS. Am. J. Pathol. 162:2003;2041-2057.
26. Hermeking H., Lengauer C., Polyak K., He T.C., Zhang L., Thiagalingam S.et al. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell. 1:1997;3-11.
27. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H.et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8:2002;500-508.
28. Desai S.D., Mao Y., Sun M., Li T.K., Wu J., Liu L.F. Ubiquitin, SUMO-1, and UCRP in camptothecin sensitivity and resistance. Ann. N.Y. Acad. Sci. 922:2000;306-308.
29. Siddoo-Atwal C., Haas A.L., Rosin M.P. Elevation of interferon beta-inducible proteins in ataxia telangiectasia cells. Cancer Res. 56:1996;443-447.
30. Han S.Y., Kim S.H., Heasley L.E. Differential gene regulation by specific gain-of-function JNK1 proteins expressed in Swiss 3T3 fibroblasts. J. Biol. Chem. 277:2002;47167-47174.
31. Ruckes T., Saul D., Van Snick J., Hermine O., Grassmann R. Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309. Blood. 98:2001;1150-1159.
32. Knight E. Jr., Cordova B. IFN-induced 15-kDa protein is released from human lymphocytes and monocytes. J. Immunol. 146:1991;2280-2284.
33. D'Cunha J., Ramanujam S., Wagner R.J., Witt P.L., Knight E. Jr., Borden E.C. In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J. Immunol. 157:1996;4100-4108.
34. Taylor J.L., D'Cunha J., Tom P., O'Brien W.J., Borden E.C. Production of ISG-15, an interferon-inducible protein, in human corneal cells. J. Interferon Cytokine Res. 16:1996;937-940.
35. Recht M., Borden E.C., Knight E. Jr. A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J. Immunol. 147:1991;2617-2623.
36. D'Cunha J., Knight E. Jr., Haas A.L., Truitt R.L., Borden E.C. Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc. Natl. Acad. Sci. U.S.A. 93:1996;211-215.
37. Padovan E., Terracciano L., Certa U., Jacobs B., Reschner A., Bolli M.et al. Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cells. Cancer Res. 62:2002;3453-3458.
38. Yap A.S., Kovacs E.M. Direct cadherin-activated cell signaling: a view from the plasma membrane. J. Cell Biol. 160:2003;11-16.
39. Remmel E., Terracciano L., Noppen C., Zajac P., Heberer M., Spagnoli G.C.et al. Modulation of dendritic cell phenotype and mobility by tumor cells in vitro. Hum. Immunol. 62:2001;39-49.
40. Jamal S., Schneider R.J. UV-induction of keratinocyte endothelin-1 downregulates E-cadherin in melanocytes and melanoma cells. J. Clin. Invest. 110:2002;443-452.
41. Loeb K.R., Haas A.L. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J. Biol. Chem. 267:1992;7806-7813.
42. Weissman A.M. Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell Biol. 2:2001;169-178.
43. Pickart C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70:2001;503-533.
44. Narasimhan J., Potter J.L., Haas A.L. Conjugation of the 15-kDa interferon-induced ubiquitin homolog is distinct from that of ubiquitin. J. Biol. Chem. 271:1996;324-330.
45. Malakhova O.A., Malakhov M.P., Hetherington C.J., Zhang D.E. Lipopolysaccharide activates the expression of ISG15 specific protease - UBP43 via interferon regulatory factor 3. J. Biol. Chem. 277:2002;14703-14711.
46. Liu M., Li X.L., Hassel B.A. Proteasomes modulate conjugation to the ubiquitin-like protein, ISG15. J. Biol. Chem. 278:2003;1594-1602.
47. Kim K.I., Zhang D.E. ISG15, not just another ubiquitin-like protein. Biochem. Biophys. Res. Commun. 307:2003;431-434.
48. Malakhov M.P., Malakhova O.A., Kim K.I., Ritchie K.J., Zhang D.E. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J. Biol. Chem. 277:2002;9976-9981.
49. Malakhova O.A., Yan M., Malakhov M.P., Yuan Y., Ritchie K.J., Kim K.I.et al. Protein ISGylation modulates the JAK-STAT signaling pathway. Genes Dev. 17:2003;455-460.
50. Ritchie K.J., Malakhov M.P., Hetherington C.J., Zhou L., Little M.T., Malakhova O.A.et al. Dysregulation of protein modification by ISG15 results in brain cell injury. Genes Dev. 16:2002;2207-2212.
51. Loeb K.R., Haas A.L. Conjugates of ubiquitin cross-reactive protein distribute in a cytoskeletal pattern. Mol. Cell Biol. 14:1994;8408-8419.
52. Kok K., Hofstra R., Pilz A., van den B.A., Terpstra P., Buys C.H.et al. A gene in the chromosomal region 3p21 with greatly reduced expression in lung cancer is similar to the gene for ubiquitin-activating enzyme. Proc. Natl. Acad. Sci. U.S.A. 90:1993;6071-6075.
53. Kok K., Naylor S.L., Buys C.H. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv. Cancer Res. 71:1997;27-92.
54. Yuan W., Krug R.M. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 20:2001;362-371.
55. de Veer M.J., Holko M., Frevel M., Walker E., Der S., Paranjape J.M.et al. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69:2001;912-920.
56. Kitareewan S., Pitha-Rowe I., Sekula D., Lowrey C.H., Nemeth M.J., Golub T.R.et al. UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 99:2002;3806-3811.
57. Hochstrasser M. Ubiquitin-dependent protein degradation. Annu. Rev. Genet. 30:1996;405-439.
58. Wilkinson K.D. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J. 11:1997;1245-1256.
59. Liu L.-Q., Ilaria R. Jr., Kingsley P.D., Iwama A., van Etten R., Palis J.et al. A novel ubiquitin-specific protease, UBP43, cloned from leukemia fusion protein AML1-ETO-expressing mice, functions in hematopoietic cell differentiation. Mol. Cell Biol. 19:1999;3029-3038.
60. Schwer H., Liu L.Q., Zhou L., Little M.T., Pan Z., Hetherington C.J.et al. Cloning and characterization of a novel human ubiquitin-specific protease, a homologue of murine UBP43 (Usp18). Genomics. 65:2000;44-52.
61. Goldberg R., Motzkin B., Marion R., Scambler P.J., Shprintzen R.J. Velo-cardio-facial syndrome: a review of 120 patients. Am. J. Med. Genet. 45:1993;313-319.
62. Zhang X., Shin J., Molitor T.W., Schook L.B., Rutherford M.S. Molecular responses of macrophages to porcine reproductive and respiratory syndrome virus infection. Virology. 262:1999;152-162.
63. Li X.L., Blackford J.A., Judge C.S., Liu M., Xiao W., Kalvakolanu D.V.et al. RNase-L-dependent destabilization of interferon-induced mRNAs. A role for the 2-5A system in attenuation of the interferon response. J. Biol. Chem. 275:2000;8880-8888.
64. Kang D., Jiang H., Wu Q., Pestka S., Fisher P.B. Cloning, and characterization of human ubiquitin-processing protease-43 from terminally differentiated human melanoma cells using a rapid subtraction hybridization protocol RaSH. Gene. 267:2001;233-242.
65. Baker R.T., Wang X.W., Woollatt E., White J.A., Sutherland G.R. Identification, functional characterization, and chromosomal localization of USP15, a novel human ubiquitin-specific protease related to the UNP oncoprotein, and a systematic nomenclature for human ubiquitin-specific proteases [In Process Citation]. Genomics. 59:1999;264-274.
66. Hamerman J.A., Hayashi F., Schroeder L.A., Gygi S.P., Haas A.L., Hampson L.et al. Serpin 2a is induced in activated macrophages, and conjugates to a ubiquitin homolog. J. Immunol. 168:2002;2415-2423.
67. Malakhov M.P., Kim K.I., Malakhova O.A., Jacobs B.S., Borden E.C., Zhang D.E. High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction. J. Biol. Chem. 278:2003;16608-16613.
68. Rhee S.G. Regulation of phosphoinositide-specific phospholipase C. Annu. Rev. Biochem. 70:2001;281-312.
69. Rebecchi M.J., Pentyala S.N. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol Rev. 80:2000;1291-1335.
70. Ji Q.S., Ermini S., Baulida J., Sun F.L., Carpenter G. Epidermal growth factor signaling and mitogenesis in Plcg1 null mouse embryonic fibroblasts. Mol. Biol. Cell. 9:1998;749-757.
71. Chang F., Steelman L.S., Lee J.T., Shelton J.G., Navolanic P.M., Blalock W.L.et al. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia. 17:2003;1263-1293.
72. Hansen T.R., Austin K.J., Perry D.J., Pru J.K., Teixeira M.G., Johnson G.A. Mechanism of action of interferon-tau in the uterus during early pregnancy. J. Reprod. Fertil. Suppl. 54:1999;329-339.
73. Barlow D.P., Randle B.J., Burke D.C. Interferon synthesis in the early post-implantation mouse embryo. Differentiation. 27:1984;229-235.
74. Fowler A.K., Reed C.D., Giron D.J. Identification of an interferon in murine placentas. Nature. 286:1980;266-267.
75. Roberts R.M., Cross J.C., Leaman D.W. Interferons as hormones of pregnancy. Endocr. Rev. 13:1992;432-452.
76. Hunt J.S. Cytokine networks in the uteroplacental unit: macrophages as pivotal regulatory cells. J. Reprod. Immunol. 16:1989;1-17.
77. Johnson G.A., Austin K.J., Van Kirk E.A. Hansen TR. Pregnancy and interferon-tau induce conjugation of bovine ubiquitin cross-reactive protein to cytosolic uterine proteins. Biol. Reprod. 58:1998;898-904.
78. Johnson G.A., Spencer T.E., Hansen T.R., Austin K.J., Burghardt R.C., Bazer F.W. Expression of the interferon tau inducible ubiquitin cross-reactive protein in the ovine uterus. Biol. Reprod. 61:1999;312-318.
79. Austin K.J., Ward S.K., Teixeira M.G., Dean V.C., Moore D.W., Hansen T.R. Ubiquitin cross-reactive protein is released by the bovine uterus in response to interferon during early pregnancy. Biol. Reprod. 54:1996;600-606.
80. Bebington C., Doherty F.J., Fleming S.D. Ubiquitin cross-reactive protein gene expression is increased in decidualized endometrial stromal cells at the initiation of pregnancy. Mol. Hum. Reprod. 5:1999;966-972.
81. Austin K.J., Bany B.M., Belden E.L., Rempel L.A., Cross J.C., Hansen T.R. Interferon-stimulated gene-15 (Isg15) expression is up-regulated in the mouse uterus in response to the implanting conceptus. Endocrinology. 144:2003;3107-3113.
82. Li X.L., Hassel B.A. Involvement of proteasomes in gene induction by interferon and double-stranded RNA. Cytokine. 14:2001;247-252.